Are you a new member? Sign up now
Login area
| Sign up
close
VALUSTAR PLUS - - 28
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C09DA03 | G | Valsartan - 160mg, Hydrochlorothiazide - 12.5mg | 7935 | 101814/1 | VALUSTAR PLUS | 28 | Tablet, film coated | Oral | Qualipharm | Atlantic Pharma Producoes Farmaceuticas SA | Portugal | 592,635 L.L | 23.08 | A1 | Tecnimede Espana Industria Farmaceutica SA | Spain | 2/5/2024 | 0 |
Drugs With Same Ingredients
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C09DA03 | B | Valsartan - 160mg, Hydrochlorothiazide - 12.5mg | 11775 | 137423/1 | CO-DIOVAN | 28 | Tablet, film coated | Oral | Khalil Fattal & Fils S.A.L. | Novartis Farma SpA | Italy | 846,621 L.L | 23.08 | A2 | Novartis Pharma AG | Switzerland | 2/5/2024 | 0 | |
| C09DA03 | G | Valsartan - 160mg, Hydrochlorothiazide - 12.5mg | 6478 | 168104/10 | ARBITEN PLUS | 30 | Tablet | Oral | Eva Pharm Plus | Joswe Medical (Jordan Sweden Medical and Sterilization Co) | Jordan | 544,256 L.L | 23.08 | A1 | 2/5/2024 | 0 | |||
| C09DA03 | G | Valsartan - 160mg, Hydrochlorothiazide - 12.5mg | 6574 | 218776/09 | CO-ANGINET | 30 | Tablet, film coated | Oral | Premium Serve Drugstore Co. P.S.D. SAL | The United Pharmaceutical Manufacturing Co Ltd | Jordan | 544,256 L.L | 23.08 | A1 | The United Pharmaceutical Manufacturing Co Ltd | Jordan | 2/5/2024 | 0 | |
| C09DA03 | G | Valsartan - 160mg, Hydrochlorothiazide - 12.5mg | 8354 | 096851/12 | CO-TABUVAN | 30 | Tablet, film coated | Oral | Mersaco | Tabuk Pharmaceutical Manufacturing Company | Saudi Arabia | 544,256 L.L | 23.08 | A1 | Tabuk Pharmaceutical Manufacturing Company | Saudi Arabia | 2/5/2024 | 0 | |
| C09DA03 | G | Valsartan - 160mg, Hydrochlorothiazide - 12.5mg | 7893 | 186256/13 | VIOSTAN PLUS 160/12.5 | 30 | Tablet, film coated | Oral | Benta Trading Co s.a.l. | Benta SAL | Lebanon | 668,082 L.L | 23.08 | A2 | 2/5/2024 | 0 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2024